Featured Research

from universities, journals, and other organizations

Increased attention needed for cancer risk from silica

Date:
December 10, 2013
Source:
American Cancer Society
Summary:
A new review highlights new developments in understanding the health effects of silica, and calls for action to reduce illness and death from silica exposure at work.

A new review highlights new developments in understanding the health effects of silica, and calls for action to reduce illness and death from silica exposure at work, including stronger regulations, heightened awareness and prevention, and increased attention to early detection of silicosis and lung cancer using low dose CT scanning.

For centuries, silica has been known to cause lung disease (silicosis). Evidence that silica causes lung cancer has been more recent, accumulating over the last several decades. Writing in CA: A Cancer Journal for Clinicians, Kyle Steenland, PhD, at the Rollins School of Public Health at Emory University in Atlanta, and Elizabeth Ward, PhD, of the American Cancer Society highlight three important developments that hold potential to prevent illness and death from silica exposure at work.

The first development is the publication of recent studies providing detailed exposure-response data, enabling regulations based on quantitative risk assessment. New studies have also shown that silica-exposed workers who do not have silicosis and who do not smoke still have increased rates of death from lung mortality.

Second, a new rule lowering the permissible occupational exposure for the estimated 2.2 million US workers currently exposed to silica is currently under consideration. Risk assessments estimate that lowering occupational exposure limits from the current to the proposed standard will reduce silicosis and lung cancer mortality to approximately one-half of the rates predicted under the current standard.

Third, low-dose computed tomography scanning has now been proven to be an effective screening method for lung cancer. The authors recommend that clinicians ask about occupational history to determine if silica exposure has occurred, and if it has, that extra attention might be given to the early detection of silicosis and lung cancer, as well as extra emphasis on quitting smoking. The authors recommend that individuals with significant occupational exposure to silica be offered screening beginning at age 50 years if they also have smoked the equivalent of one pack a day for at least 20 pack-years; what experts call 20 pack-years of smoking.

The report says while there is some low-level silica exposure on beaches and in ambient air in general, there is no evidence such low-level exposure causes health effects. The more concerning exposures occur on the job, most often in the construction industry. Exposure occurs when workers cut, grind, crush, or drill silica-containing materials such as concrete, masonry, tile, and rock. About 320,000 workers are exposed in general industry operations such as brick, concrete, and pottery manufacturing, as well as operations using sand products, such as foundry work. Others are exposed during sandblasting. Silica exposure also occurs from hydraulic fracturing (fracking) of oil and gas wells.

The most effective measures for the control of occupational silica exposures include banning sandblasting, substituting metal grits for abrasive blasting, modifying processes and equipment, and controlling dust transmission by using enclosures, air curtains, water spray, and ventilation techniques, and the use of personal protective equipment.

"Current regulations have substantially reduced silicosis death rates in the United States, but new cases of silicosis continue to be diagnosed," says Dr. Steenland. "And while the lung cancer risk associated with silica exposure is not as large as some other lung carcinogens, like smoking or asbestos exposure, there is strong and consistent evidence that silica exposure increases lung cancer risk."


Story Source:

The above story is based on materials provided by American Cancer Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. Kyle Steenland, PhD; Elizabeth Ward, PhD. Silica: A Lung Carcinogen. CA: A Cancer Journal for Clinicians, December 2013

Cite This Page:

American Cancer Society. "Increased attention needed for cancer risk from silica." ScienceDaily. ScienceDaily, 10 December 2013. <www.sciencedaily.com/releases/2013/12/131210102056.htm>.
American Cancer Society. (2013, December 10). Increased attention needed for cancer risk from silica. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/12/131210102056.htm
American Cancer Society. "Increased attention needed for cancer risk from silica." ScienceDaily. www.sciencedaily.com/releases/2013/12/131210102056.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins